Audentes Therapeutics Inc. (BOLD)

41.43 +0.78 (+1.919%)

IEX Real-Time Price

July 20, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 40.65

Price Open 40.61

Volume: 304,075

Avg Volume: 411,357

Market Cap: 1.52B

P/E Ratio -12.52

52 Wk Range 15.74-46.1799



BOLD Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-06-29
36.21M
2.21M
4.63
6.10%

2018-06-15
36.22M
2.07M
4.47
5.72%

2018-05-31
36.22M
1.99M
3.74
5.49%

2018-05-15
36.22M
2.23M
7.71
6.15%




BOLD Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-10
Q1 2018
N/A
-0.81 (8)
0.00
0.00

2018-05-09
Q1 2018
AMC
-0.81 (8)
-0.74
0.07

2018-03-08
Q4 2017
N/A
-0.92 (7)
-0.82
0.10

2017-11-14
Q3 2017
AMC
-0.86 (5)
-0.82
0.10

News

Genomic Medicine Q2 2018: Do Earnings Matter? (2018-07-10 20:17 SeekingAlpha)

My spreadsheets are now locked and loaded for the 2Q18 earnings season which begs the question: How much do earnings and estimates really matter for this group? Most of these companies are precommercial or even preclinical. Yet in a few weeks earnings will roll out with traditional media procl…

 


Statistics

Shares Outstanding: 36.74M

Top 15 Institution Percent: N/A

Price To Sales: N/A

Price To Book: 4.24

Revenue: N/A

Gross Profit: N/A

Cash: 301.05M

Debt: N/A

Return On Assets: -38.02

Return On Equity: -41.48

Profit Margin: N/A

Price History

Beta: 1.22

50-day Moving Avg: 38.43

200-day Moving Avg: 33.24

YTD Change: 22.18

5-day Change: 9.89

1-month Change: 0.75

3-month Change: 9.37

6-month Change: 11.04

1-year Change: 96.44

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Audentes Therapeutics Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.audentestx.com

Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.